Estimation of XDR-TB in European part of the Russian Federation Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014 Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Tuberculosis treatment completion in migrants, St.-Petersburg, Russian Federation Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012 Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014
Hospitalization for pneumonia in the Veneto Region (North-East Italy), 2004-2012 Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Extrapulmonary Tuberculosis: 21 Patients at Western Visayas Medical Center DOTS Clinic, Philippines (January 2016 to December 2017) Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Source: Eur Respir J 2002; 19: 765-775 Year: 2002
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018 Year: 2018
Mesothelioma in South African miners 1975-2013 Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies Year: 2015
ERS International Congress, Madrid, 2019: highlights from the Epidemiology and Environment Assembly Source: ERJ Open Res, 6 (1) 00320-2019; 10.1183/23120541.00320-2019 Year: 2020
Risk factors associated with fluoroquinolones-resistance of M.tuberculosis in Novosibirsk Oblast, Russian Federation: Results of retrospective cohort study Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013
XDR-TB prevalence in some regions of the Russian Federation Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017
Drug resistance of Mycobacterium tuberculosis in the Ural region of Russian Federation Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
National Program of Tuberculosis Control: results of its application in Romania (Bucharest) Source: Eur Respir J 2005; 26: Suppl. 49, 197s Year: 2005
Drug resistance and HIV rates are high in Eastern European patients with Tuberculosis in a South East London Hospital Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Population-based study of fluoroquinolone-resistance in clinical isolates of Mycobacterium tuberculosis in Novosibirsk Oblast, Russian Federation Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly Source: ERJ Open Res, 5 (1) 00176-2018; 10.1183/23120541.00176-2018 Year: 2019
Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society) Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
European Union Standards for Tuberculosis Care Source: Eur Respir J 2012; 39: 807-819 Year: 2012